PSMA PET/CT对原发性前列腺癌局部分期的准确性及观察者内与观察者间变异性
本研究纳入600例接受机器人辅助根治性前列腺切除术前行PSMA PET/CT分期的中高危原发性前列腺癌患者,以根治性前列腺切除标本的病理T分期为参考标准,评估基于PSMA PET/CT的分子影像局部肿瘤分期(miT分期)的诊断准确性及观察者内与观察者间变异性。结果显示,miT分期对pT3a期的敏感性58%、特异性59%,对≥pT3b期的敏感性30%、特异性97%,对总体≥pT3期的敏感性68%、特异性61%;不同示踪剂间诊断准确性无统计学显著差异。观察者内一致性为中等至高度(≥T3期κ 0.70,≥T3b期κ 0.75),观察者间一致性为中等(≥T3期κ 0.47,≥T3b期κ 0.41)。
要点
- PSMA PET/CT的miT分期对≥pT3b期特异性97%、敏感性30%,对pT3a期敏感性58%、特异性59%。
- 对总体≥pT3期,miT分期的敏感性68%、特异性61%。
- 观察者内一致性≥T3期κ 0.70、≥T3b期κ 0.75,观察者间一致性≥T3期κ 0.47、≥T3b期κ 0.41。
核心结论
- 在600例新诊断中高危原发性前列腺癌患者的多中心研究中,以根治性前列腺切除标本病理T分期为参考标准,PSMA PET/CT可能对局部肿瘤分期有价值。
- PSMA PET/CT评估肿瘤范围的观察者内与观察者间变异性为中等至高度。
研究设计与样本
- 研究纳入600例在机器人辅助根治性前列腺切除术前接受分期PSMA PET/CT的患者。
- 在579例PSMA阳性原发前列腺肿瘤中,比较四位核医学医师评估的miT分期与按ISUP方案判定的pT分期。
- 在100例代表性患者子集中,使用Kappa估计评估观察者内与观察者间变异性。
主要发现
- miT分期对pT3a期的敏感性58%、特异性59%。
- miT分期对≥pT3b期的敏感性30%、特异性97%。
- miT分期对总体≥pT3期的敏感性68%、特异性61%。
- 不同示踪剂间诊断准确性无统计学显著差异。
- 观察者内一致性:≥T3期κ 0.70,≥T3b期κ 0.75;观察者间一致性:≥T3期κ 0.47,≥T3b期κ 0.41。
关键数值与推荐
- miT分期对pT3a期:敏感性58%、特异性59%。
- miT分期对≥pT3b期:敏感性30%、特异性97%。
- miT分期对总体≥pT3期:敏感性68%、特异性61%。
- 观察者内一致性:≥T3期κ 0.70,≥T3b期κ 0.75;观察者间一致性:≥T3期κ 0.47,≥T3b期κ 0.41。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prostate-specific membrane antigen (PSMA) positron emission tomography/ computed tomography (PET/CT) is recognized as the most accurate imaging modality for detection of metastatic high-risk prostate cancer (PCa). Its role in the local staging of disease is yet unclear. We assessed the intra- and interobserver variability, as well as the diagnostic accuracy of the PSMA PET/CT based molecular imaging local tumour stage (miT-stage) for the local tumour stage assessment in a large, multicentre cohort of patients with intermediate and high-risk primary PCa, with the radical prostatectomy specimen (pT-stage) serving as the reference standard. METHODS: A total of 600 patients who underwent staging PSMA PET/CT before robot-assisted radical prostatectomy was studied. In 579 PSMA positive primary prostate tumours a comparison was made between miT-stage as assessed by four nuclear physicians and the pT-stage according to ISUP protocol. Sensitivity, specificity and diagnostic accuracy were determined. In a representative subset of 100 patients, the intra-and interobserver variability were assessed using Kappa-estimates. RESULTS: The sensitivity and specificity of the PSMA PET/CT based miT-stage were 58% and 59% for pT3a-stage, 30% and 97% for ≥ pT3b-stage, and 68% and 61% for overall ≥ pT3-stage, respectively. No statistically significant differences in diagnostic accuracy were found between tracers. We found a substantial intra-observer agreement for PSMA PET/CT assessment of ≥ T3-stage (k 0.70) and ≥ T3b-stage (k 0.75), whereas the interobserver agreement for the assessment of ≥ T3-stage (k 0.47) and ≥ T3b-stage (k 0.41) were moderate. CONCLUSION: In a large, multicentre study evaluating 600 patients with newly diagnosed intermediate and high-risk PCa, we showed that PSMA PET/CT may have a value in local tumour staging when pathological tumour stage in the radical prostatectomy specimen was used as the reference standard. The intra-observer and interobserver variability of assessment of tumour extent on PSMA PET/CT was moderate to substantial.
引用
- Donswijk ML, Ettema RH, Meijer D, et al. The accuracy and intra- and interobserver variability of PSMA PET/CT for the local staging of primary prostate cancer. Eur J Nucl Med Mol Imaging. 2024. PMID: 38273003. doi:10.1007/s00259-024-06594-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。